Johnson & Johnson COVID Vaccine Problems Reported In 15 Out Of 7 Million Doses

Colorado is set to put the Janssen vaccine, also known as the Johnson & Johnson vaccine, back into use after an advisory committee recommended to the Centers for Disease Control and Prevention and the Food and Drug Administration that it be re-authorized for use with label warning of the potential of blood clots. The clots, though rare among the over seven million doses of the Janssen vaccine given, have impacted 15 women, 13 of whom have been under the age of 50.